about
Clinical Use And Limitations Of Non-Invasive Electrophysiological Tests In Patients With Atrial FibrillationAssociation between atrial fibrillatory rate and heart rate variability in patients with atrial fibrillation and congestive heart failure.Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure.Reduced Irregularity of Ventricular Response During Atrial Fibrillation and Long-term Outcome in Patients With Heart Failure.Documentation of atrial fibrillation prior to first-ever ischemic stroke.Left atrial posterior wall thickness in patients with and without atrial fibrillation: data from 298 consecutive autopsies.In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.Age-related changes in P wave morphology in healthy subjects.Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members.Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.Peripheral microvascular function is altered in young individuals at risk for hypertrophic cardiomyopathy and correlates with myocardial diastolic function.Analysis of the surface electrocardiogram for monitoring and predicting antiarrhythmic drug effects in atrial fibrillation.Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic strokeGenetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population-based studyInteratrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities.Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCIGenetic polymorphisms for estimating risk of atrial fibrillation: a literature-based meta-analysisAtrial conduction and atrial fibrillation: what can we learn from surface ECG?Permanent atrial fibrillation in patients without structural heart disease is not associated with signs of infection by Chlamydia pneumoniae and Helicobacter pylori.P-wave morphology: underlying mechanisms and clinical implications.Atrial fibrillatory rate in the clinical context: natural course and prediction of intervention outcome.Noninvasive characterization of atrioventricular conduction in patients with atrial fibrillation.Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?Current controversies in determining the main mechanisms of atrial fibrillation.Cardiovascular drug utilization post-implant is related to clinical outcome in heart failure patients receiving cardiac resynchronization therapy.Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.Long-Term Results of Cardiac Resynchronization Therapy: A Comparison between CRT-Pacemakers versus Primary Prophylactic CRT-Defibrillators.Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy.Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure.Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization TherapyAltered interatrial conduction detected in MADIT II patients bound to develop atrial fibrillation.Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram.Predictors of ventricular fibrillation at reperfusion in patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.Atrial time and voltage dispersion are both needed to predict new-onset atrial fibrillation in ischemic stroke patients.Ventricular high-rate episodes predict increased mortality in heart failure patients treated with cardiac resynchronization therapy.Right precordial-directed electrocardiographical markers identify arrhythmogenic right ventricular cardiomyopathy in the absence of conventional depolarization or repolarization abnormalities.
P50
Q28070194-B1916EA0-81D9-46AD-8EE5-C37EF7CA8381Q30426251-D6DEA11B-8BE3-4763-8BEE-7E047E684C54Q30557370-5B51FF60-DAAD-4E7C-BA6D-D828DFA1EA84Q30569240-656323DA-8D2F-4CF9-86EB-5BFA885BAF8BQ31144906-CDE96D47-C6CA-4488-A6FB-3C54982CC472Q31147099-87755041-E865-405D-B7FC-600410BD8398Q33162028-F820EAF5-506D-4450-A11F-59277196E908Q33163293-D6D07832-3429-4137-B585-05B789C75234Q33292258-EB5283A3-1827-4123-A1F6-0C1AE5C93AAFQ34421298-A28E841D-409F-41BC-A01D-11DA886D8749Q34782131-87DD8B5A-FEFB-43F5-B8BA-04EF0F671486Q35205077-A12A13D2-59AC-4699-8A48-C035D011A1F2Q35582341-D445CE5A-A369-49E8-B3F4-3FDF735489E5Q35583070-66C642DA-B036-4C1D-9655-595E9718E4CCQ36045458-B0B2A9E5-DD55-4E1C-9143-4759E535ECA6Q36181311-65B6114D-4635-4BF5-BDD3-E4630792016CQ36623041-B93FE294-EF8D-4F73-AD95-F4220CBA5C42Q36981070-8F689C72-17D8-424F-8B6E-BC2052961145Q37140981-BC18655A-37AC-42C2-8899-972F94DB9F0DQ37148981-FDB4DE47-C4D4-43E4-B94B-77136E6FC85CQ37276917-AEE0944D-4C9E-41CE-BC43-D686F1079A8AQ37856602-01F33DE6-EE39-4A46-87B1-E019528BD09EQ38027880-C75F55D3-20F6-4A7F-9782-9EAF93E9B152Q38264239-412E5CBE-34C3-4DF1-95E3-96C25B74897EQ38577651-0E8249BC-412F-432E-B37D-61BC7EA333AFQ38701353-F67E7ECF-01DD-4AB4-BD92-6FADACFAE894Q38780259-AFB19338-E698-4BC7-A083-6BFFA91795E7Q38960847-848E2AAD-21A7-4DFD-B48A-D4D374DBEF22Q38981336-EED18BE7-5A06-4EF5-A1C2-24562BB31206Q39021660-9E7E48F3-5D67-4D8C-A4C7-1915D4A428B3Q39027627-6E934890-3F7E-4929-B0B5-4D0B720CF562Q39190366-8E3633BB-1893-4D95-A014-B989213A564DQ39228463-AE6D2E0B-D78A-4840-A40C-771D3EFED7C7Q39707648-83D7CBC0-D989-4F1A-9D66-7DFAE564BADFQ39962309-2CF3D1C2-DDD3-4EED-B29C-B074B12E31B3Q40041527-CE77A5F9-BAD5-4D71-B24F-F71DA4091BB1Q40246632-571C2E00-3F35-451E-A639-174D8E8A0E66Q41111709-48C06B08-20F8-4FD1-B734-684EB82D88EBQ41470169-A5A53854-EA00-4220-8C80-0A05BCF00CCAQ42377424-F9C3D094-D9D0-4845-9467-D8FAAF016594
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pyotr G Platonov
@ast
Pyotr G Platonov
@en
Pyotr G Platonov
@es
Pyotr G Platonov
@nl
type
label
Pyotr G Platonov
@ast
Pyotr G Platonov
@en
Pyotr G Platonov
@es
Pyotr G Platonov
@nl
prefLabel
Pyotr G Platonov
@ast
Pyotr G Platonov
@en
Pyotr G Platonov
@es
Pyotr G Platonov
@nl
P106
P31
P496
0000-0002-5592-8717